Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 4, 2026

Stock market today: S&P 500, Nasdaq fall for 2nd day as tech slides on AI worries with Google earnings ahead

View original at finance.yahoo.com
Stock market today: S&P 500, Nasdaq fall for 2nd day as tech slides on AI worries with Google earnings ahead US stocks mostly fell on Wednesday as Wall Street assessed a fresh wave of earnings and waited for Alphabet (GOOG, GOOGL) results, eyeing the fallout from an AI-stoked slump in software and tech stocks…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Data center orders at Eaton roughly tripled in Q4 over prior year

    80% confidence
  • Eli Lilly expanded manufacturing capacity and through US government agreement opened new access to obesity medicines

    80% confidence
  • Hyperscalers reconfirmed their capex plans for 2026 which supports Eaton's projects

    80% confidence
  • Treasury Secretary does not have authority to buy bitcoin or other cryptos and FSOC chair does not have that authority

    80% confidence
  • Kevin Warsh will likely follow the pattern FOMC has shown for years and let data tell him what's the right policy

    80% confidence
  • Bitcoin plummet could cascade into self-reinforcing death spiral that could hit companies with big bitcoin treasuries

    80% confidence
  • US economic growth in 2026 is likely to be front-loaded with Q1 at 2.6%, Q2 at 3%, Q3 and Q4 at 2%

    80% confidence
  • Job creation took a step back in 2025 with private employers adding 398,000 jobs down from 771,000 in 2024

    80% confidence
  • While seeing continuous and dramatic slowdown in job creation for past three years, wage growth has remained stable

    80% confidence
  • Multi-tenant and new cloud players are extremely active and these projects will take years to complete

    80% confidence
  • Eli Lilly reached millions more patients launching Inluriyo, expanding Mounjaro and Kisunla globally, and submitting orforglipron for approval

    80% confidence
  • Consumer stimulus from One Big Beautiful Act and government shutdown likely to boost Q1 growth by 0.5% to 1%

    80% confidence
  • January tends to be the largest net job loss month as seasonal hiring ahead of holidays unwinds

    80% confidence
  • Better-than-expected earnings are no longer enough to convince the market unless company can show AI will be tailwind rather than headwind

    80% confidence
  • Software stock sell-off has more room to run

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,351 source documents archived
Query this data → isubstrate.com